RE:RE:Wedbush and Cormark UpdatesSpeculator...You are probably right.
What analyst would issue, and twice reiterate, a $5, $10 and $22 1 year target on a collapsing, near death micro cap biotech that hasn't been over $1 in nearly a decade?
And why wouldn't this same biotech, which has spent most of this same decade under 30 cents, make it readily available to shareholders and the market in general?
I have to acknowledge that I have never actually seen these reports. I have just had them read to me by a somewhat reluctant broker. He may have been questioning their validity as well.
A 22 cent stock, with a soon to be withdrawn trial, having a $5 target price? Actually you are right, they probably don't exist.
I wrote the company and my position off years ago, so at least the idea was a bit of entertainment before the trial collapses.